General Western Blot Reagents
Abcam 20X Wash Buffer.
20X Wash Buffer.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Bis(3,5-dibromosalicyl) fumarate, hemoglobin acylating agent, 5G
MW 671.9 Da, Purity >93%. Potent hemoglobin acylating agent. Cross-links beta chains of hemoglobin. Acylating and anti-sickling agent. Active in vitro and in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam CTPB, p300 HAT activator, 1MG
MW 554.1 Da, Purity >99%. Small-molecule p300 histone acetyltransferase (HAT) activator. Benzamide. Active in vitro and in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam MMP-9 inhibitor, 500UG
MW 511.6 Da, Purity >95%. MMP-9 inhibitor. Role in tumor cell migration, invasion and angiogenesis. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam PBFI AM, fluorescent K+ binding probe, 1MG
MW 1171.1 Da, Purity >94%. Cell-permeable, fluorescent K+ binding probe (Kd = 5 mM). Active *in vitro*. Non-specific esterases hydrolyze the AM esters to produce the water-soluble form of PBFI.Excitation is 340/390 nm.
The product is subject to the following: Abcam Restricted Use Statement
Abcam RGD (Arg-Gly-Asp), sequence involved in cell adhesion, 10MG
MW 346.34 Da, Purity >95%. RGD (Arg-Gly-Asp), sequence involved in cell adhesion. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Aeroplysinin (Aeroplysinin-1), antiangiogenic agent, 100UG
MW 338.98 Da, Purity >95%. Potent antiangiogenic agent. Inhibits COX-2 expression. Selectivity for endothelial cells. Able to induce apoptosis via capsase activation, chromatin condensation and nuclear fragmentation. Antibiotic and cytotoxic effects (IC₅₀ = 3 μm) and displays a wide-spectrum antitumor activity. Active in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam Agomelatine, MT1/MT2 agonist and 5-HT2C antagonist, 50MG
MW 243.3 Da, Purity >99%. Potent MT1/MT2 agonist (Ki values are 0.1 and 0.12 nM, respectively). 5-HT2C antagonist (IC50 = 270 nM). Shows antidepressant effects *in vivo*. Orally active.
The product is subject to the following: Abcam Restricted Use Statement
Abcam 4-Aminophenyl phosphate monosodium salt, Alkaline phosphatase substrate, 10MG
MW 211.09 Da, Purity >99%. Substrate for electrochemical alkaline phosphatase measurement. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam ACTH (1-24) (human), ACTH/MC2 receptor agonist, 1MG
MW 2933.4 Da. ACTH (1-24) (human), ACTH/MC2 receptor agonist. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam 4-Aminophenyl phosphate monosodium salt, Alkaline phosphatase substrate, 50MG
MW 211.09 Da, Purity >99%. Substrate for electrochemical alkaline phosphatase measurement. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam BRL-50481, Selective PDE7 inhibitor, 50MG
MW 244.27 Da, Purity >98%. Selective, competitive PDE7 inhibitor (IC₅₀ values are 0.15 and 12.1 μm for PDE7A and PDE7B respectively). Active in vivo and in vitro. Potentiates the anti-inflammatory effect of PDE4 inhibitor rolipram (ab120031). Cell and blood-brain barrier permeable.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Polygodial, TRPA1 agonist, 25MG
MW 234.33 Da, Purity >97%. Selective TRPA1 agonist (EC₅₀ = 400 nM). Antinociceptive in vivo. Inhibits mitochondrial ATPase (IC₅₀ = 15 μM). Antifungal.
The product is subject to the following: Abcam Restricted Use Statement
Abcam SMI-4a, ATP-competitive Pim kinase inhibitor, 25MG
MW 273.23 Da. Potent, selective, cell-permeable, ATP-competitive Pim-1 kinase inhibitor (IC₅₀ = 17 nM). Moderately potent against Pim-2 kinase. Selective versus a panel of other serine/threonine and tyrosine kinases. Inhibits the growth of myeloid and lymphoid cell lines. Induces cell cycle arrest in leukemia and prostate cancer cells.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Piracetam, positive allosteric modulator of AMPA receptors, 50MG
MW 142.16 Da. Positive allosteric modulator at AMPA receptors. Nootropic agent and GABA (ab120359) derivative. Potentiates cholinergic and glutamatergic neurotransmission via modulation of ion flux. Variety of biological effects including neuroprotection, anticonvulsant properties and reduced vascular endothelium adhesion. Active in vivo. Also available in simple stock solutions (ab146734) - add 1 ml of water to get an exact, ready-to-use concentration.
The product is subject to the following: Abcam Restricted Use Statement